Broxaterol


Broxaterol is a beta-2 adrenergic receptor agonist used primarily in the treatment of asthma and other conditions involving bronchoconstriction. It functions by relaxing the smooth muscles of the bronchi, leading to bronchodilation and improved airflow.
Pharmacology[edit]
Broxaterol acts on the beta-2 adrenergic receptors located in the bronchial smooth muscle. Activation of these receptors leads to the activation of adenylate cyclase, which increases the levels of cyclic adenosine monophosphate (cAMP). Elevated cAMP levels result in the relaxation of bronchial smooth muscle and subsequent bronchodilation.
Clinical Use[edit]
Broxaterol is indicated for the management of asthma and chronic obstructive pulmonary disease (COPD). It is administered via inhalation, which allows for direct delivery to the lungs, minimizing systemic side effects. The onset of action is rapid, making it suitable for the relief of acute bronchospasm.
Synthesis[edit]
The synthesis of Broxaterol involves a cycloaddition reaction, as depicted in the accompanying image. This process is a key step in the formation of the active compound, allowing for the precise construction of its chemical structure.
Mechanism of Action[edit]
Broxaterol's mechanism of action is primarily through the stimulation of beta-2 adrenergic receptors. This stimulation leads to a cascade of intracellular events that result in the relaxation of bronchial smooth muscle. The increased cAMP levels inhibit the phosphorylation of myosin light chain kinase, reducing muscle contraction and promoting bronchodilation.
Side Effects[edit]
Common side effects of Broxaterol include tremor, tachycardia, and nervousness. These effects are generally mild and result from the systemic absorption of the drug. In rare cases, more severe cardiovascular effects can occur, particularly in patients with pre-existing heart conditions.
Related Pages[edit]
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
| Major chemical drug groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian